Lara Marques

454 total citations · 1 hit paper
16 papers, 220 citations indexed

About

Lara Marques is a scholar working on Molecular Biology, Animal Science and Zoology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lara Marques has authored 16 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Animal Science and Zoology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lara Marques's work include Receptor Mechanisms and Signaling (4 papers), Pharmacological Effects and Assays (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Lara Marques is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Pharmacological Effects and Assays (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Lara Marques collaborates with scholars based in Portugal and United States. Lara Marques's co-authors include Nuno Vale, Mariana Pereira, Joana Santos, Bárbara Costa, Isabel Silva, Stephan Schmidt, Abigail Silva, Rui Amaral Mendes, Pedro Vieira‐Baptista and Carlos Sousa and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Nanomaterials.

In The Last Decade

Lara Marques

13 papers receiving 212 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare

2024 124 citations Lara Marques, Bárbara Costa et al. Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lara Marques Portugal	6	63	29	27	24	23	16	220
Mariana Pereira Portugal	7	77 1.2×	14 0.5×	36 1.3×	9 0.4×	32 1.4×	21	237
Mir S. Adil United States	9	154 2.4×	44 1.5×	14 0.5×	21 0.9×	13 0.6×	25	372
Jingyan Li China	10	64 1.0×	11 0.4×	31 1.1×	40 1.7×	33 1.4×	23	278
Cezar Login Romania	9	78 1.2×	36 1.2×	16 0.6×	36 1.5×	7 0.3×	20	304
Guanzhen Wang China	9	120 1.9×	12 0.4×	35 1.3×	23 1.0×	11 0.5×	17	391
Mesfer Al Shahrani Saudi Arabia	9	119 1.9×	17 0.6×	9 0.3×	28 1.2×	8 0.3×	28	291
Sumit Birangal India	11	60 1.0×	25 0.9×	20 0.7×	14 0.6×	28 1.2×	33	302
Bedangshu Saikia India	6	107 1.7×	46 1.6×	26 1.0×	8 0.3×	13 0.6×	13	321
Gregory Koytiger Israel	2	117 1.9×	16 0.6×	9 0.3×	20 0.8×	89 3.9×	3	271
Guize Feng China	10	157 2.5×	37 1.3×	6 0.2×	23 1.0×	9 0.4×	17	295

Countries citing papers authored by Lara Marques

Since Specialization

Citations

This map shows the geographic impact of Lara Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Marques more than expected).

Fields of papers citing papers by Lara Marques

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Marques. The network helps show where Lara Marques may publish in the future.

Co-authorship network of co-authors of Lara Marques

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Marques. A scholar is included among the top collaborators of Lara Marques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Marques. Lara Marques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Marques, Lara & Nuno Vale. (2025). Organoids as a Revolutionary Data Source for Pharmacokinetic Modeling: A Comprehensive Review. SHILAP Revista de lepidopterología. 5(4). 74–74.

Marques, Lara & Nuno Vale. (2025). A Review on New Frontiers in Drug-Drug Interaction Predictions and Safety Evaluations with In Vitro Cellular Models. Pharmaceutics. 17(6). 747–747.

Marques, Lara & Nuno Vale. (2024). Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients. Pharmaceutics. 17(1). 39–39.

Marques, Lara, Bárbara Costa, Mariana Pereira, et al.. (2024). Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare. Pharmaceutics. 16(3). 332–332. 124 indexed citations breakdown →

Marques, Lara, et al.. (2024). Enhancing Prostate and Bladder Cancer Treatment: Exploring the Synergistic Potential of Entecavir and 5-Fluorouracil Combinations. SHILAP Revista de lepidopterología. 4(2). 185–202. 1 indexed citations

Costa, Bárbara, et al.. (2024). Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes. Journal of Clinical Medicine. 13(14). 4113–4113. 2 indexed citations

Marques, Lara & Nuno Vale. (2024). Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data. Pharmaceutics. 16(7). 881–881. 1 indexed citations

Marques, Lara, et al.. (2023). The Effects of Chitosan on the Healing Process of Oral Mucosa: An Observational Cohort Feasibility Split-Mouth Study. Nanomaterials. 13(4). 706–706. 16 indexed citations

Marques, Lara & Nuno Vale. (2023). Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine. Pharmaceutics. 15(6). 1586–1586. 9 indexed citations

10.

Correia, Ana Salomé, Lara Marques, & Nuno Vale. (2023). The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin. Current Issues in Molecular Biology. 45(4). 3333–3346. 2 indexed citations

11.

Marques, Lara & Nuno Vale. (2023). Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions. SHILAP Revista de lepidopterología. 3(1). 296–316. 3 indexed citations

12.

Correia, Ana Salomé, Lara Marques, Armando Cardoso, & Nuno Vale. (2023). Exploring the Role of Drug Repurposing in Bridging the Hypoxia–Depression Connection. Membranes. 13(9). 800–800. 1 indexed citations

13.

Marques, Lara, Bárbara Costa, & Nuno Vale. (2022). New Data for Nebivolol after In Silico PK Study: Focus on Young Patients and Dosage Regimen. Pharmaceutics. 14(9). 1911–1911. 2 indexed citations

14.

Marques, Lara & Nuno Vale. (2022). Salbutamol in the Management of Asthma: A Review. International Journal of Molecular Sciences. 23(22). 14207–14207. 40 indexed citations

15.

Vale, Nuno, Mariana Pereira, Joana Santos, et al.. (2022). Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches. International Journal of Molecular Sciences. 24(1). 69–69. 6 indexed citations

16.

Marques, Lara, et al.. (2022). Therapeutic Options for Chlamydia trachomatis Infection: Present and Future. Antibiotics. 11(11). 1634–1634. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact